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response. Several RGD motif-interacting
integrins (v1, 31, v3, v5, v6, 51, M2, and
L2) have previously been shown to serve
as secondary receptors promoting Ad
internalization into different cell types
in vitro. This study highlights the role of
b3 integrins not only for viral entry but
also for IL-1a-driven inflammation. Like
IL-1b, IL-1a is synthesized as a prepro-
tein, pre-IL-1a (Dinarello, 1996); however,
unlike IL-1b, IL-1a is not processed by
caspase-1-containing inflammasomes.
Rather, pre-IL1a is processed in the cyto-
plasm by neutral proteases, including cal-
pains, thereby leading to the translocation
of the N-terminal IL-1a propiece (IL-1a-
NTP) to the nucleus, whereas mature
IL-1a is released from the cell. Staining
of spleen sections indicated that IL-1a
was primarily localized to the nuclei of in-
fected cells, suggesting that IL-1a was
processed in adenovirus-infected cells.
Adenovirus-induced Il1a gene transcrip-
tion and synthesis occurred normally in
b3-integrin-deficient mice; however, pre-
IL1a was not detected in the nucleus.
Therefore, the b3 integrin pathway
appears to regulate pre-IL-1a processing
rather than transcription of the IL-1a gene.
The role of b3 integrin in regulating IL-1a
activity is shown in Figure 1. Viral RGD-
b3 integrin associations also lead to the
uptake of virus and rupture of endo-
somes, thereby amplifying Il1a gene tran-
scription, synthesis, and processing. How
pre-IL-1a processing is regulated and the
role of calpain in these events will require
follow-up studies. It will be intriguing to
examine IL-1a and cellular integrins
further in innate immunity to other viruses
and bacterial pathogens. Moreoever,
defining the relative role of the N-terminal
IL-1a propiece and the mature IL-1a
released from cells will likely uncover
novel roles for this cytokine in host-
defense and pathogenesis.
Adenoviral vectors induce significant
inflammation and overcoming this
obstacle will be important for the full
potential of this approach to be realized.
The discovery of the b3-integrin-depen-
dent IL-1a pathway as the primary medi-
ator of inflammation in vivo identifies
a pathway that could be targeted thera-
peutically to overcome this obstacle. A
feasible strategy could be to modify the
viral capsid to alleviate b3-integrin-driven
inflammation. Additionally, the inclusion
of immunomodulatory genes in gene
therapy vectors that interfere with b3-
integrin signaling, with IL-1a production
and/or with IL-1a-IL1R1 function, could
also be a worthwhile endeavor. Notably,
inflammation driven by adenoviral vectors
is not always a bad thing and could
be beneficial and desirable in certain
instances; for example, the ability of the
viral vector to trigger IL-1a-driven inflam-
mation could be useful in vaccine devel-
opment or cancer gene therapy in which
inflammation is a desirable adjuvant or
bystander effect.
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The transcription factor KLF2 directs expression of receptors involved in trafficking of naive T cells. In this
issue of Immunity, Weinreich et al. (2009) demonstrate that KLF2 additionally represses IL-4 production,
which otherwise induces CXCR3 expression.
The adaptive immune system faces
a formidable logistic challenge, which is
to respond quickly to an invading path-
ogen while maintaining a large repertoire
of different antigen (Ag)-specific lympho-
cytes. Thus, only few T cells are able
to recognize and become activated by a
given Ag derived frommicrobial intruders,
whereas microbes may enter the body
through any epithelial surface, such as
skin, lungs, or gastrointestinal tract. To
meet this challenge, a surveillance system
has evolved in mammals, and such a
system ensures continuous encounters
of lymphocytes with Ag-presenting cells
in strategically positioned secondary
lymphoid organs (SLOs) (Junt et al.,
2008). Blood-borne naive lymphocytesImmunity 31, July 17, 2009 ª2009 Elsevier Inc. 9
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including lymph nodes and spleen, in
which they scan Ag-presenting cells for
the presence of their cognate peptide.
In case their specific Ag is not encoun-
tered, naive lymphocytes leave lymphoid
tissue via efferent lymphatic vessels,
which eventually drain to the blood
vascular system. Thus, the intrinsic ability
of naive T and B cells to continuously re-
circulate for weeks, months, or perhaps
even years through the host endows the
adaptive immune system with the
capacity to respond quickly to microbes
at any location while maintaining a highly
diverse repertoire. In addition, lympho-
cyte homing also provides these cells
with access to prosurvival factors present
in lymphoid tissue niches, therefore regu-
lating immune system homeostasis (Surh
and Sprent, 2008).
The acquisition of a naive, recirculating
T cell phenotype occurs at the late stages
of thymocyte development. More pre-
cisely, single positive (SP) thymocytes start
expressing homing receptors for secon-
dary lymphoid organs, including CD62L
and high amounts of CCR7, which are
required to enter and move inside periph-
eral lymph nodes, spleen, and other SLOs.
SP thymocytes also increase expression
of the sphingosine-1-phosphate receptor
1 (S1P1), which is critical for thymocyte
exit into S1P-rich blood vasculature and
lymphocyteegress intoefferent lymphatics
(Cyster, 2005). A key insight into the
genetic control of the naive lymphocyte
phenotype came from the identification of
the transcription factor krueppel-like factor
2 (KLF2) as a key regulator of CD62L and
S1P1 expression (Carlson et al., 2006).
KLF2 (previously known as LKLF) belongs
to a group of widely expressed zinc finger
transcription factors, which can exert
both activation and repressive functions.
KLF-2 is expressed during the transition
of double positive (DP) to SP thymocytes
and remains highly expressed in naive
T cells. Because genetic deficiency of
KLF2 results in embryonic lethality, pre-
vious studies have addressed the role of
KLF2 in T cell development with fetal liver
chimeras or the blastocyst complementa-
tion system (Carlson et al., 2006; Kuo
et al., 1997). Consistent with its regulation
of S1P1 expression, KLF2-deficient SP
thymocytes accumulated within the
thymus, accompanied by a profound lym-
phopenia in the periphery,with themajority10 Immunity 31, July 17, 2009 ª2009 Elseviof remaining T cells displaying a CD62Llo
‘‘activated’’ phenotype. These observa-
tions supported a model in which thymic
egress is strongly impaired in the absence
of KLF2, and the few remaining peripheral
T cells are excluded from lymph nodes
because of the low expression of appro-
priate homing molecules.
An alternative role for KLF2 during T cell
trafficking was recently proposed, on the
basis of the finding that T cell-restricted
KLF2 deficiency led to increased expres-
sion of inflammatory chemokine recep-
tors, including CXCR3, CCR3, and
CCR5, on CD4+ T cells (Sebzda et al.,
2008). According to this model, KLF2-
deficient T cells would still leave the
thymus fairly efficiently, but would then
enter nonlymphoid sites attracted via
inflammatory chemokines. In this issue of
Immunity,Weinreich et al. (2009) re-exam-
ined the contribution of KLF2 for repres-
sion of inflammatory chemokine recep-
tors, coming up with a rather different
conclusion. Using conditional KLF-2 defi-
cient mice crossed with CD4-cre mice,
the authors confirmed the upregulation of
CXCR3 (but not other inflammatory che-
mokine receptors) on SP thymocytes, in
particular on CD8+ cells. The fact that
Weinreich et al. (2009) did not identify
increased expression of additional inflam-
matory chemokine receptors may be
linkedwith different inducermouse strains
used in the present study and may be a
result of their careful exclusion of non-ab
TCR lymphocytes, which are more abun-
dant in absence of KLF2. Importantly, on
the basis of results with mixed bone
marrow chimeras, the authors provide
solid evidence for a cell-nonautonomous
effect of KLF2 deficiency on CXCR3
expression. When mixed with a majority
of KLF2-deficient thymocytes, wild-type
thymocytes also became CXCR3+, while
maintaining high expression of CD62L
and S1P1, which allowed for normal
thymic egress. These findings clearly
uncouple expression of inflammatory che-
mokine receptors from a direct regulation
through KLF2. When searching for the
basis for this bystander induction of
CXCR3, the authors identified increased
IL-4 production in KLF2-deficient thymo-
cytes. When added to wild-type thymo-
cytes or splenocytes, IL-4 increased
CXCR3 expression on CD8+ T cells.
CXCR3 expression on thymocytes was
strictly dependent on the IL-4R and theer Inc.transcription factor eomesodermin. Taken
together, the data presented byWeinreich
et al. (2009) uncover an important function
for KLF2 as a suppressor for uncontrolled
IL-4 production, as well as that of
additional inflammatory cytokines. The
author’s data support a model in which
SP thymocytes and naive lymphocytes
increase their CXCR3 expression when
exposed to IL-4, independent of their
own KLF2 expression (Figure 1). This is
also supported by the uncoupled expres-
sion of CXCR3 and KLF2 on CD4+ and
CD8+ memory T cells isolated from
knockin mice expressing a GFP-KLF2-
fusion protein.
These data uncover a radically new
aspectof themolecular control of anonac-
tivated, naive phenotype on T cell circula-
tion, which is a more ‘‘active’’ process
than previously anticipated. How this
KLF2-dependent suppression of exces-
sive IL-4 production works is currently
unclear, andwhether this is amoregeneral
phenomenon affecting additional cyto-
kines needs to be further explored. It is
interesting to note, though, that activa-
tion of T cells transiently decreases KLF2
expression, thus potentially allowing for
expression of inflammatory cytokines.
KLF2 is subsequently re-expressed in
effector cells, in particular when T cells
are cocultured with IL-2, IL-7, or IL-15,
reminiscent of a feedback mechanism to
avoid excessive cytokine production. Of
note, addition of IL-4 to activated T cells
prevents KLF2 re-expression (Bai et al.,
2007). In combination with the data pre-
sented by Weinreich et al. (2009), KLF2
expression and IL-4 signaling appear
mutually exclusive—in absence of KLF2,
more IL-4 is produced, which in turn
prevents de novo synthesis of KLF2.
How do these findings enhance our
understanding of T cell homeostasis and
activation in vivo? KLF2 is clearly required
for T cell homeostasis through positive re-
gulation of homing receptors for secon-
dary lymphoid organs, in which these
cells receive survival signals through
Tcell receptor-MHC interactions, IL-7, and
homeostatic chemokines. Furthermore,
KLF2 represses inflammatory cytokine
production, in particular IL-4, which other-
wise leads to increased CXCR3 expres-
sion. IL-4-producing follicular helper
CD4+ T cells are mainly localized to B cell
follicles during helminth infections. These
cells are low in CD62L andCCR7 and their
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suggests low amounts of S1P1 (Fazilleau
et al., 2009). These observations would
be consistent with downregulation of
KLF2 in follicular helper T cells, although
this needs tobeexperimentally addressed.
It is striking that IL-4 increases CXCR3
expression on naive CD8+ T cells because
this chemokine receptor is usually associ-
ated with T helper 1 cell responses in
memory CD4+ T cells. This suggests that
the expression of chemokine receptors is
differentially regulated during activation
of CD4+ versus CD8+ T cells, perhaps re-
flecting an increased necessity for CD8+
T cells to home to inflammatory sites. In
a model of acute inflammation, CD62L
CCR7 CXCR3+ CD8+ effector memory
T cells are recruited to draining lymph
node in which they act to terminate an
ongoing immune response (Guarda et al.,
2007). However, the kinetics and precise
microenvironmental niches in which
CD8+ T cells become exposed to IL-4
during adaptive immune responses are
poorly described to date. Thus, a future
challenge will be to explore the precise
kinetics of CXCR3 expression in vivo and
its correlation with IL-4 production during
ongoing immune responses—the GFP-
KLF2 fusion protein-expressing mouse
model presented in the accompanying
publication should be an excellent tool to
this end.
Figure 1. Schematic Functions of KLF2 for the Maintenance of a Naive T Cell Phenotype
Driven by FOXO1 (and perhaps FOXO3) transcription factors in the late stage of thymocyte development,
KLF2 regulates expression of CD62L and S1P1. Furthermore, CCR7 surface expression is increased.
Whereas CD62L and CCR7 regulate trafficking into and within lymphoid tissue, S1P1 allows release of
SP thymocytes and naive T cells into the blood and lymphatic vascular systems. A new function for
KLF2 described in this issue is the repression of cytokines, in particular IL-4. Unrestrained IL-4 production
leads via the transcription factor eomesodermin to increased CXCR3 expression, even on KLF-sufficient
bystander cells. Continuous arrows indicate direct transcriptional regulation.ImmunIn summary, the authors provide
compelling evidence for a central role of
KLF2 in negatively regulating cytokine
production, in addition to its previously
known roleof positively regulatingmarkers
related to T cell trafficking. Excessive IL-4
production then drives CXCR3 expres-
sion, in particular on CD8+ T cells. This
cell-nonautonomous effect of KLF2 defi-
ciency was made only detectable through
the mixed chimera approach the authors
have employed. It will be exciting to learn
more about the kinetics of KLF2 expres-
sion, cytokine production, and chemokine
receptor expression during immune chal-
lenges.
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